Clinical Trials on Autoimmune Polyglandular Syndrome Type 2 in United Kingdom
Total 7382 results
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Louis H. Weimer, MDNo longer availableLambert Eaton Myasthenic Syndrome (LEMS)United States
-
Norfolk and Norwich University Hospitals NHS Foundation...King's College London; University of Leeds; Belfast Health and Social Care Trust and other collaboratorsCompletedDiabetesUnited Kingdom
-
University Hospitals Bristol and Weston NHS Foundation...CompletedType 1 DiabetesUnited Kingdom
-
Medtronic DiabetesCompletedType 1 Diabetes | Type 2 DiabetesUnited Kingdom, Australia
-
Imperial College LondonRecruitingDiabetes Complications | Type 2 Diabetes | Acute Myocardial Infarction | Acute Myocardial Infarction With ST ElevationUnited Kingdom
-
Catalyst Pharmaceuticals, Inc.No longer availableLambert-Eaton Myasthenic Syndrome | Congenital Myasthenic Syndrome | Nystagmus, AcquiredUnited States
-
Loughborough UniversityUnknownGlucose Metabolism Disorders | Insulin Resistance | Type 2 Diabetes | Metabolic DiseaseUnited Kingdom
-
Cardiff UniversityExperimental Cancer Medicine Centres; Leukaemia & Lymphoma Research GroupCompletedHigh Risk Myelodysplastic Syndrome | Acute Myeloid LeukaemiaUnited Kingdom
-
University of ExeterRoyal Devon and Exeter NHS Foundation TrustRecruitingHypoglycemia | Type 1 DiabetesUnited Kingdom
-
Liverpool John Moores UniversityCompleted
-
The Royal Bournemouth HospitalCompletedType 1 Diabetes MellitusUnited Kingdom
-
Dr Bob RyderAssociation of British Clinical DiabetologistsCompletedObesity | Type 2 Diabetes | Obstructive Sleep ApnoeaUnited Kingdom
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United Kingdom
-
University of CambridgeCambridge University Hospitals NHS Foundation TrustCompletedType 1 DiabetesUnited Kingdom
-
University of PortsmouthPortsmouth Hospitals NHS TrustCompleted
-
Catalyst Pharmaceuticals, Inc.CompletedA Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)Lambert Eaton Myasthenic SyndromeUnited States, Spain, Serbia, Russian Federation, Hungary, France, Germany, Poland
-
Liverpool John Moores UniversityCompleted
-
Sirtris, a GSK CompanyGlaxoSmithKlineCompleted
-
Tameside General HospitalManchester Metropolitan UniversityCompletedDiabetic Angiopathies | Bone Diseases, MetabolicUnited Kingdom
-
Habitual Health LtdLindus HealthEnrolling by invitation
-
Joslin Diabetes CenterCompletedObesity | Metabolic Syndrome | Type 2 DiabetesUnited States
-
UCB CelltechPRA Health SciencesTerminatedPrimary Sjögren's SyndromeFrance, Italy, Spain, Sweden, United Kingdom
-
The Royal Bournemouth HospitalCompletedType 1 DiabetesUnited Kingdom
-
University of CambridgeCambridge University Hospitals NHS Foundation TrustCompletedType 1 DiabetesUnited Kingdom
-
Eli Lilly and CompanyActive, not recruitingGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2DUnited States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
-
Buckinghamshire Healthcare NHS TrustAnimas CorporationTerminated
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United Kingdom
-
Cleveland Clinic LondonRecruitingObesity | Diabetes Mellitus, Type 2United Kingdom
-
Imperial College LondonCompletedObesity | Diabetes Mellitus, Type 2United Kingdom
-
University of LeicesterUniversity of Oxford; University of ManchesterRecruitingDiabetes Mellitus, Type 2 | Heart Failure, Diastolic | Heart Failure With Preserved Ejection Fraction | Diabetes Mellitus Type 2 in Obese | Obesity Adult OnsetUnited Kingdom
-
University of LeicesterJDRF UKRecruitingType 1 Diabetes | Patient Reported Outcomes | Insulin Pump TherapyUnited Kingdom
-
Queen's University, BelfastWestern Health and Social Care TrustCompletedDiabetes Mellitus, Type 2United Kingdom
-
University of LeicesterUniversity Hospitals, LeicesterCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2United Kingdom
-
University of CambridgeCambridge University Hospitals NHS Foundation TrustCompleted
-
Buckinghamshire Healthcare NHS TrustAnimas CorporationCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusIreland, United Kingdom
-
University of CambridgeNorfolk and Norwich University Hospitals NHS Foundation Trust; Barts & The... and other collaboratorsRecruiting
-
MedImmune LLCAmgenCompletedPrimary Sjögren's SyndromeUnited States, Sweden, France, United Kingdom
-
University of LeedsCompletedDiabetes Mellitus, Type 2United Kingdom
-
University of DundeeCompletedType 1 DiabetesUnited Kingdom
-
Sheffield Hallam UniversitySheffield Children's NHS Foundation TrustCompleted
-
University of NottinghamRecruitingObesity | Type 2 Diabetes | Alcohol Use Disorder | Chronic Liver Disease | Persistently Elevated ALTUnited Kingdom
-
Eric Stephen Winer, MDRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Relatives to/Carers of Patients | Healthcare ProfessionalsSpain, Algeria, China, India, Mexico, Russian Federation, Turkey, Germany, Poland, Japan, Netherlands, Italy, Canada, United Kingdom, Denmark, France, United States
-
The Royal Bournemouth HospitalCompletedObesity | Type 2 DiabetesUnited Kingdom
-
King's College LondonDiabetes UK; Guy's and St Thomas' Foundation NHS TrustCompletedDiabetes Mellitus, Type 1United Kingdom
-
Sirtris, a GSK CompanyGlaxoSmithKlineCompletedDiabetes Mellitus, Type 2 | Healthy VolunteerUnited Kingdom
-
KeyBioscience AGNordic Bioscience A/SCompletedType 2 Diabetes MellitusDenmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
-
Cell Medica LtdUniversity College, London; Cell Therapy CatapultCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)United Kingdom, Germany, Belgium